Evidence map›Paper›PMID 19129483›Full record

ArticleJournal of leukocyte biology2009

Activation of nucleotide oligomerization domain 2 exacerbates a murine model of proteoglycan-induced arthritis.

H L Rosenzweig, M M Jann, T T Glant, T M Martin, S R Planck, W van Eden, P J S van Kooten, R A Flavell, K S Kobayashi, J T Rosenbaum and 1 more

Open access · greenAbstract read
In one paragraph

Article in Journal of leukocyte biology, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.3field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 19 citations in OpenAlex.

  1. Uveitis-mediated immune cell invasion through the extracellular matrix of the lens capsule.FASEB journal : official publication of the Federation of American Societies for Experimental Biology · 2022
    Article
  2. Nod2 Deficiency Augments Th17 Responses and Exacerbates Autoimmune Arthritis.Journal of immunology (Baltimore, Md. : 1950) · 2018
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Dectin-1 and NOD2 mediate cathepsin activation in zymosan-induced arthritis in mice.Inflammation research : official journal of the European Histamine Research Society ... [et al.] · 2011
    Article
  9. Article
  10. Article
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

H L RosenzweigCasey Eye Institute, Oregon Health and Science University, Portland, OR 97219, USA. rosenzwh@ohsu.edu
M M Jann
T T Glant
T M Martin
S R Planck
W van Eden
P J S van Kooten
R A Flavell
K S Kobayashi
J T Rosenbaum
M P Davey
Oregon Health & Science University · USPortland VA Medical Center · USUtrecht University · NLHarvard University · USRush University Medical Center · USYale University · US

Funding

Nod2-mediated regulation of intestinal homeostasisR01DK074738 · NIDDK · DANA-FARBER CANCER INST · PI KOBAYASHI, KOICHI S · 2007 to 2011
$1.4M
Investigation of Nod2: Implications for UveitisF32EY017254 · NEI · OREGON HEALTH & SCIENCE UNIVERSITY · PI ROSENZWEIG, HOLLY LALLMAN · 2006 to 2008
$139k
NEI NIH HHS F32 EY017254NEI NIH HHS F32-EY017254NIDDK NIH HHS R01 DK074738
6 · The paper itself

Abstract

In addition to its role in innate immunity, nucleotide oligomerization domain 2 (NOD2) has been shown to play a suppressive role in models of colitis. Notably, mutations in NOD2 cause the inherited granulomatous disease of the joints called Blau syndrome, thereby linking NOD2 with joint disease as well. However, the role of NOD2 in joint inflammation has not been clarified. We demonstrate here that NOD2 is functional within the mouse joint and promotes inflammation, as locally or systemically administered muramyl dipeptide (MDP; the NOD2 agonist) resulted in significant joint inflammation that was abolished in NOD2-deficient mice. We then sought to investigate the role of NOD2 in a mouse model of inflammatory arthritis dependent on adaptive immunity using TCR-transgenic mice whose T cells recognized the dominant epitope of proteoglycan (PG). Mice immunized with PG in the presence of MDP developed a more severe inflammatory arthritis and histopathology within the joints. Antigen-specific activation of splenocytes was enhanced by MDP with respect to IFN-gamma production, which would be consistent with the Th1-mediated disease in vivo. Intriguingly, NOD2 deficiency did not alter the PG-induced arthritis, indicating that NOD2 does not play an essential role in this model of joint disease when it is not activated by MDP. In conclusion, we demonstrate that in a model of inflammatory arthritis dependent on T and B cell priming, NOD2 activation potentiates disease. However, the absence of NOD2 does not alter the course of inflammatory arthritis, in contrast to models of intestinal inflammation.

Indexed as

AnimalsAntigen PresentationArthritisB-LymphocytesDisease Models, AnimalImmunity, InnateInflammationMiceMice, KnockoutMice, TransgenicNod2 Signaling Adaptor ProteinProteoglycansT-LymphocytesNod2 Signaling Adaptor ProteinProteoglycans

Identifiers

PMID19129483
PMCPMC2718807
OpenAlexW2143292302

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.